Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
BioAge Labs’ $238 Million Upsized Initial Public Offering
CARGO Therapeutics’ $281.3 Million Initial Public Offering
Wilson Sonsini Goodrich & Rosati and Latham & Watkins advised CARGO Therapeutics, Inc. on the offering, and Cooley advised the underwriters. CARGO Therapeutics, Inc. (CARGO) (Nasdaq:CRGX)...
Neumora Therapeutics’ $250.1 Million Initial Public Offering
Latham & Watkins advised Neumora, and Cooley advised the underwriters. Neumora Therapeutics, Inc. announced the pricing of its initial public offering of 14,710,000 shares of its common...
Savara’s $80 Million Common Stock Offering
Holland & Knight advised Savara, and Cooley advised the underwriters. Savara announced on July 13, 2023, the pricing of an underwritten offering of 21,000,000 shares of...
Lulu’s Fashion Lounge Holdings’ $92 Million Initial Public Offering
Latham & Watkins represented Lulu’s in the offering while Cooley advised the underwriters. Lulu’s Fashion Lounge Holdings, Inc., a customer driven, digitally native women’s fashion brand, has...